Vaccinex shareholders approve 1:15 reverse stock split; board sets ratio, effective Sept 2023

VACCINEX, INC.

Stockholders approved reverse stock split amendment with 43,464,926 votes for, 2,041,760 against, 135,207 abstained.
Board set reverse split ratio at 1:15; effective date expected in September 2023, subject to final determination.
Prior to effective time, company will disclose final timing and additional details.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

VACCINEX, INC. shareholders approved Approve amendment to certificate of incorporation to effect a reverse stock split at the 2023-09-08 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-09-08

Exact text from the filing

Proposal 1. The Company’s stockholders approved and adopted an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of its issued common stock with one of several specified ratios between one-for-eight and one-for-fifteen shares (the “Reverse Stock Split”), at the discretion of the Company’s Board of Directors (the “Board”). Votes For Votes Against Votes Abstained 43,464,926 2,041,760 135,207

View on SEC.gov

Browse all shareholder votes →

VACCINEX, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-233884

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.